Evaluation of the Efficacy of Xaliproden (SR57746A) in Preventing the Neurotoxicity of Oxaliplatin / 5FU/LV Chemotherapy.

Clinical trial NCT00305188 · COMPLETED

Trial details

NCT number: NCT00305188
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Metastases Colorectal Neoplasms Colorectal Carcinoma

Start date: 2005-12-01
Primary completion: 2009-10-01
Enrollment: 879

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.